Systemic Sclerosis Linked to Higher Lung Cancer Risk
Researchers found that individuals with this autoimmune condition may face a significantly increased risk of developing lung cancer.
Updated on Oct. 5, 2026 in Cancer
Live Poll
Do you believe patients with chronic conditions should undergo more frequent cancer screenings?
A study of 180 patients has identified a 5-fold increase in lung cancer risk for those with systemic sclerosis, with women showing a nearly 10-fold higher risk compared to the general population. These findings highlight a critical need for monitoring in this patient population.
Why it matters
Researchers launched this analysis to clarify whether the connection between systemic sclerosis and lung cancer is causal, potentially altering future screening and early detection strategies for affected patients. The results emphasize the importance of vigilant health management for those living with the disease.
This research analyzed an inception cohort of 180 patients followed for 2,110 person-years, alongside a meta-analysis of 27,563 patients. The study found a 5-fold increase in lung cancer risk, though outcomes were noted to vary significantly between genders.
The details
The study utilized an academic inception cohort to track lung cancer incidence starting from the onset of systemic sclerosis. Risk factors for higher lung cancer incidence included a history of smoking and the diffuse cutaneous subtype of the disease, while digital ulcers were found to have an inverse association with risk. The findings suggest that the chronic inflammation characteristic of systemic sclerosis may play a role in the progression of pulmonary malignancies.
Timeline
January 1995 to December 2020: Enrollment period for the systemic sclerosis inception cohort.
December 2024: Conclusion of the follow-up period for the inception cohort.
October 2026: Official publication of the research findings.
Health Landscape
This development aligns with the ongoing clinical investigation into autoimmune-related malignancy risks, where chronic inflammation is increasingly recognized as a potential driver for secondary disease. It marks a departure from earlier, smaller studies by providing a standardized incidence ratio that helps define the scope of cancer risk in these patients.
Patients with systemic sclerosis should consult their physician regarding their personal risk factors, such as smoking history or specific disease subtypes. Discussing appropriate screening intervals for lung cancer may be a proactive step for those with a long-standing diagnosis.
The takeaway
The study highlights a significantly elevated risk of lung cancer for patients with systemic sclerosis, particularly among women. Patients should work with their healthcare team to review their individual risk profile and determine if increased surveillance is appropriate for their specific case.
Further reading
For more information on the latest research and diagnostic advancements, visit the Cancer section.
Source note: This article includes information reported by Ajmc.
Live Poll
Do you believe patients with chronic conditions should undergo more frequent cancer screenings?
